Poland Germany And Switzerland Home Parenteral Nutrition And Home Enteral Nutrition Market
Market Size in USD Billion
CAGR : %
Forecast Period |
2024 –2031 |
Market Size (Base Year) |
USD 458.50 Million |
Market Size (Forecast Year) |
USD 615.21 Million |
CAGR |
|
Major Markets Players |
|
Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) Market, By Product & Services (Product and Services), Care Type (Pre-Operative Care and Post-Operative Care), Patient Type (Neurology Problems, Cancer, Abnormal Bowel Function, Crohn's Disease, Gastroparesis, and Others), Distribution Channel (B2B Channel and B2C Channel) - Industry Trends and Forecast to 2031.
Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) Market Analysis and Insights
According to an article published by BMC, in Poland, between 2015 and 2019, the prevalence of prostate cancer increased, with significant disparities observed between subregions with the lowest and highest incidence rates. In 2021, there was a marked disproportionate rise in cancer incidence rates. As more individuals are diagnosed with cancer, the demand for specialized long-term nutritional support to manage their health and improve treatment outcomes will increase, leading to an expansion of these markets.
Data Bridge Market Research analyzes that the Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) market is expected to reach USD 615.21 million by 2031 from USD 458.50 million in 2023, growing at a CAGR of 4.1% in the forecast period of 2024 to 2031.
Report Metric |
Details |
Forecast Period |
2024 to 2031 |
Base Year |
2023 |
Historic Years |
2022 (Customizable to 2016–2021) |
Quantitative Units |
Revenue in USD Million |
Segments Covered |
Product & Services (Product and Services), Care Type (Pre-Operative Care and Post-Operative Care), Patient Type (Neurology Problems, Cancer, Abnormal Bowel Function, Crohn's Disease, Gastroparesis, and Others), Distribution Channel (B2B Channel and B2C Channel) |
Countries Covered |
Germany, Switzerland, and Poland |
Market Players Covered |
Fresenius SE & Co. KGaA, Nestlé, Abbott, B. Braun SE, Baxter, CSL, Nutricia, Pfizer Inc. and others |
Market Definition
Home enteral nutrition is primarily for patients in whom there is a reduction in oral intake below the amount needed to maintain nutrition or hydration (i.e., oral failure), whereas home parenteral nutrition is used for patients when oral-enteral nutrition is temporarily or permanently impossible or absorption insufficient to maintain nutrition or hydration (i.e., intestinal failure). The development of home delivery of these therapies has revolutionized the field of clinical nutrition.
Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Driver
- Growing Aging Population
The aging populations in Poland, Germany and Switzerland are significantly driving the Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) markets. In Poland, the demographic shift is resulting in a higher prevalence of chronic illnesses such as diabetes, cardiovascular diseases, and cancer, which often require long-term nutritional support. Elderly patients frequently struggle with nutrient intake due to swallowing difficulties and gastrointestinal disorders, increasing the demand for HEN and HPN. These therapies provide continuous, personalized care at home, enhancing quality of life and reducing hospital readmissions.
Restraint
- Lack of Awareness about Malnutrition
Malnutrition can lead to serious health issues, including stunted growth, eye problems, diabetes, and heart diseases. Moreover, malnutrition affects independence and the inability to be active. The lacks of awareness regarding the severe consequences of malnutrition, including death and severe health problems for patients, serves as a significant restraint for the growth of the home parenteral and enteral nutrition market. Malnutrition can lead to weakened immune systems, prolonged hospital stays, and increased healthcare costs. Despite its critical role in patient recovery and well-being, the understanding among both healthcare providers and the general public about the importance of adequate nutrition remains insufficient. This lack of awareness translates into delayed or inadequate referrals for nutrition support, underutilization of home nutrition therapies, and challenges in obtaining timely access to specialized nutritional care. Moreover, misconceptions or limited education about the benefits of home-based nutrition solutions further hinder adoption rates among patients who could benefit from these therapies.
Opportunity
- Adopting Digital Health Solutions
Adopting digital health solutions in the Home Parenteral Nutrition and Home Enteral Nutrition market offers the opportunity to revolutionize patient care by enhancing monitoring, communication, and treatment adherence. Leveraging telehealth platforms, mobile apps, and wearable devices enables real-time remote monitoring of patient vitals, nutritional intake, and treatment progress. By empowering patients to actively engage in their care and facilitating seamless communication with healthcare providers, digital health solutions improve patient outcomes, increase treatment adherence, and drive efficiency in home-based nutritional therapy.
Challenge
- Technical Requirements Restricts the Prevalence of Therapy
The technical needs requirements for Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) make it tough for this markets to grow. From the surgical procedures, complicated and expensive equipment to the requirement for specialized training and knowledge in using them by caregivers and requirement for evaluation, along with dealing with rules, making different systems work together, and handling patient data carefully. So, these technical demands collectively hinder accessibility, affordability, and adoption of HPN and HEN therapies. All these factors make it harder for people to access and afford HPN and HEN to make these treatments more widely available, we need simpler solutions, easier rules, better training, and ways to keep patient information safe.
Recent Developments
- In January 2024, Abbott, a one of global leader in science-based nutrition, stated today the launch of its new PROTALITY brand. The high-protein nutrition shake is the first product in this line to support the growing number of adults interested in following weight loss while maintaining muscle mass and good nutrition.
- In October 2023, Nestlé announced a collaboration with Amwell to enhance patient outcomes through digital nutrition solutions. Their first initiative, the Advanced Surgical Nutrition Automated Care Program, combined Amwell’s virtual technology with Nestlé’s Impact ADVANCED RECOVERY drink to support surgical recovery. This collaboration benefited Nestlé by strengthening its position in the Home Enteral Nutrition (HEN) market, showcasing their commitment to integrating nutrition and technology to improve clinical outcomes
- In February 2022, Nestlé supported Feeding Tube Awareness Week from February 7th to 11th, 2022, to highlight the benefits of feeding tubes as life-saving interventions. The company shared information about their medical nutrition products, including nutritional supplements, tube feeds, and food thickeners. This initiative raised awareness about tube feeding and the importance of medical nutrition, benefiting Nestlé Health Science by showcasing their expertise and commitment to improving patient care. Through this effort, they strengthened their relationship with healthcare professionals and the public
- In June 2022, Upstream Rehabilitation Acquires Crescent Physical Therapy in South Carolina. Chris Kilgus fulfilled his goal of bringing outpatient physical therapy services back to his hometown of Orangeburg, S.C.
Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) Market Scope
Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) Market is segmented into four notable segments based on product & services, care type, patient type, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Product and Services
- Product
- Services
On the basis of product and services, the Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) market is segmented into product and services.
Care Type
- Pre-Operative Care
- Post-Operative Care
On the basis of care type, the Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) market is segmented into pre-operative care and post-operative care.
Patient Type
- Neurology Problems
- Cancer
- Abnormal Bowel Function
- Crohn's Disease
- Gastroparesis
- Others
On the basis of patient type, the Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) market is segmented into neurology problems, cancer, abnormal bowel function, crohn's disease, gastroparesis, others.
Distribution Channel
- B2B channel
- B2C channel
On the basis of distribution channel, the Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) market is segmented into B2B channel and B2C channel.
Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) Market Regional Analysis/Insights
The Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) market is segmented into four notable segments based on product & services, care type, patient type, and distribution channel.
The countries covered in this Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) market report are Germany, Switzerland, Poland.
Germany is expected to dominate the Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) market, owing to high number of people suffering from chronic diseases in Germany.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of large services company and their challenges faced due to large or scarce competition from local and domestic players and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) Market Share Analysis
The Poland, Germany and Switzerland Home Parenteral Nutrition (HPN) and Home Enteral Nutrition (HEN) market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.
Some of the major market players operating in the market are Fresenius SE & Co. KGaA, Nestlé, Abbott, B. Braun SE, Baxter, CSL, Nutricia, Pfizer Inc. and others.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE POLAND, GERMANY AND SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 YEARS CONSIDERED FOR THE STUDY
2.3 DBMR TRIPOD DATA VALIDATION MODEL
2.4 POLAND, GERMANY AND SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 INCREASING PREVALENCE OF CHRONIC DISEASES IS DRIVING THE GROWTH OF THE POLAND, GERMANY AND SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET FROM 2024 TO 2031
4.2 THE PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE POLAND, GERMANY AND SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET IN 2024 AND 2031
4.3 PESTEL ANALYSIS POLAND
4.4 PESTEL ANALYSIS GERMANY
4.5 PESTEL ANALYSIS SWITZERLAND
4.6 PORTER’S FIVE FORCES POLAND
4.7 PORTER’S FIVE FORCES GERMANY
4.8 PORTER’S FIVE FORCES SWITZERLAND
4.9 PREVALENCE AND PATIENT TYPE
5 PATIENT JOURNEY
5.1 POLAND
5.2 GERMANY
5.3 SWITZERLAND
6 HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: REGULATIONS
6.1 EUROPEAN SOCIETY FOR CLINICAL NUTRITION AND METABOLISM (ESPEN PRACTICAL GUIDELINES: HOME PARENTERAL NUTRITION (HPN))
6.2 EUROPEAN SOCIETY FOR CLINICAL NUTRITION AND METABOLISM (ESPEN PRACTICAL GUIDELINES: HOME ENTERAL NUTRITION (HEN))
6.3 INSTITUTE OF FOOD AND NUTRITION (POLAND):
6.4 SWISS FEDERAL INSTITUTE OF TECHNOLOGY (ETH ZURICH):
6.5 GERMAN SOCIETY FOR NUTRITIONAL MEDICINE (DGEM):
6.6 POLISH SOCIETY FOR PARENTERAL AND ENTERAL NUTRITION (POLSPEN):
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 GROWING AGING POPULATION
7.1.2 RISING PREVALENCE OF CHRONIC DISEASES
7.1.3 COST-EFFECTIVENESS OF HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN)
7.2 RESTRAINTS
7.2.1 LACK OF AWARENESS ABOUT MALNUTRITION
7.2.2 INFECTION CAUSES DURING PARENTERAL ADMINISTRATION
7.2.3 RISK MANAGEMENT OF PARENTAL NUTRITION AND ENTERAL IN INTENSIVE CARE UNITS
7.3 OPPORTUNITIES
7.3.1 ADOPTING DIGITAL HEALTH SOLUTIONS
7.3.2 IMPLEMENTING PERSONALIZED NUTRITION STRATEGIES
7.3.3 ENSURING COMPLIANCE WITH REIMBURSEMENT POLICIES
7.4 CHALLENGES
7.4.1 TECHNICAL REQUIREMENTS RESTRICTS THE PREVALENCE OF THERAPY
7.4.2 REGULATORY GUIDELINES ACT AS HURDLES FOR THERAPY PROVIDERS
8 POLAND, GERMANY AND SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY PATIENT TYPE
8.1 OVERVIEW
8.2 NEUROLOGY PROBLEMS
8.3 CANCER
8.4 ABNORMAL BOWEL FUNCTION
8.5 CROHN'S DISEASE
8.6 GASTROPARESIS
8.7 OTHERS
9 POLAND, GERMANY AND SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY CARE TYPE
9.1 OVERVIEW
9.2 PRE-OPERATIVE CARE
9.3 POST-OPERATIVE CARE
10 POLAND, GERMANY AND SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY PRODUCT & SERVICES
10.1 OVERVIEW
10.2 PRODUCT
10.2.1 HOME ENTERAL NUTRITION
10.2.1.1 TUBE FEED
10.2.1.1.1 LIPID EMULSION
10.2.1.2.2 AMINO ACID DEXTROSE
10.2.1.3.3 OTHERS
10.2.1.2 SIP FEED
10.2.1.2.1 NUTRITIONAL DRINK
10.2.1.2.2 FRUIT JUICE BASED ORAL NUTRITION
10.2.1.2.3 OTHERS
10.2.1.3 STANDARD FORMULAS
10.2.1.4 HYDROLYZED OR SEMI-ELEMENTAL FORMULAS
10.2.1.5 DISEASE-SPECIFIC FORMULAS
10.2.1.6 OTHERS
10.2.1.7 COFFEE FLAVOR
10.2.1.8 CHOCOLATE FLAVOR
10.2.1.9 STRAWBERRY FLAVOR
10.2.1.10 OTHERS
10.2.1.11 LIQUID FORMULA
10.2.1.12 SEMI-SOLID FORMULA
10.2.1.13 NEUROLOGICAL PROBLEM
10.2.1.14 CANCER
10.2.1.15 GASTROPARESIS
10.2.1.16 OTHERS
10.2.2 HOME PARENTERAL NUTRITION
10.2.2.1 NEW-BORN
10.2.2.2 CHILDREN
10.2.2.3 ADULTS
10.2.2.4 SHORT BOWEL SYNDROME
10.2.2.5 CANCER
10.2.2.6 CROHN'S DISEASE
10.2.2.7 ABNORMAL BOWEL FUNCTION
10.2.2.8 ISCHEMIC BOWEL DISEASE
10.2.2.9 OTHERS
10.3 SERVICES
10.3.1 HOME ENTERAL NUTRITION
10.3.2 HOME PARENTERAL NUTRITION
11 POLAND, GERMANY AND SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 B2B CHANNEL
11.3 B2C CHANNEL
12 POLAND, GERMANY AND SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: GERMANY
12.2 COMPANY SHARE ANALYSIS: SWITZERLAND
12.3 COMPANY SHARE ANALYSIS: POLAND
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 FRESENIUS SE & CO. KGAA
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 PRODUCT/ SERVICE PORTFOLIO
14.1.4 RECENT DEVELOPMENTS
14.2 NESTLÉ
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 BRAND PORTFOLIO
14.2.4 RECENT DEVELOPMENTS
14.3 ABBOTT
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 PRODUCT/ SERVICE PORTFOLIO
14.3.4 RECENT DEVELOPMENTS
14.4 B. BRAUN SE
14.4.1 COMPANY SNAPSHOT
14.4.2 PRODUCT/ SERVICE PORTFOLIO
14.4.3 RECENT DEVELOPMENT
14.5 BAXTER
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 PRODUCT/SERVICE PORTFOLIO
14.5.4 RECENT UPDATES
14.6 IHRE APOTHEKER
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENT
14.7 NUTRICIA
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT/ SERVICE PORTFOLIO
14.7.3 RECENT DEVELOPMENT
14.8 PFIZER INC.
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 SHARE OF PERSONS AGED 60 AND MORE IN THE TOTAL NUMBER OF POPULATION AS OF 31 DECEMBER
TABLE 2 COUNTRIES WITH THE PERCENTAGE OF OLDER ADULTS
TABLE 3 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 4 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 5 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 6 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY CARE TYPE, 2022-2031 (USD THOUSAND)
TABLE 7 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY CARE TYPE, 2022-2031 (USD THOUSAND)
TABLE 8 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY CARE TYPE, 2022-2031 (USD THOUSAND)
TABLE 9 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY PRODUCT & SERVICES, 2022-2031 (USD THOUSAND)
TABLE 10 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY PRODUCT & SERVICES, 2022-2031 (USD THOUSAND)
TABLE 11 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY PRODUCT & SERVICES, 2022-2031 (USD THOUSAND)
TABLE 12 POLAND PRODUCT IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 13 GERMANY PRODUCT IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 14 SWITZERLAND PRODUCT IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND)
TABLE 15 POLAND HOME ENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 16 GERMANY HOME ENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 17 SWITZERLAND HOME ENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 18 POLAND TUBE FEED IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 19 GERMANY TUBE FEED IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 20 SWITZERLAND TUBE FEED IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 21 POLAND SIP FEED IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 22 GERMANY SIP FEED IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 23 SWITZERLAND SIP FEED IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 24 POLAND HOME ENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY NUTRITION FORMULA, 2022-2031 (USD THOUSAND)
TABLE 25 GERMANY HOME ENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY NUTRITION FORMULA, 2022-2031 (USD THOUSAND)
TABLE 26 SWITZERLAND HOME ENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY NUTRITION FORMULA, 2022-2031 (USD THOUSAND)
TABLE 27 POLAND HOME ENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY FLAVOR, 2022-2031 (USD THOUSAND)
TABLE 28 GERMANY HOME ENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY FLAVOR, 2022-2031 (USD THOUSAND)
TABLE 29 SWITZERLAND HOME ENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY FLAVOR, 2022-2031 (USD THOUSAND)
TABLE 30 POLAND HOME ENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY FORM, 2022-2031 (USD THOUSAND)
TABLE 31 GERMANY HOME ENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY FORM, 2022-2031 (USD THOUSAND)
TABLE 32 SWITZERLAND HOME ENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY FORM, 2022-2031 (USD THOUSAND)
TABLE 33 POLAND HOME ENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 34 GERMANY HOME ENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 35 SWITZERLAND HOME ENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 36 POLAND HOME PARENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 37 GERMANY HOME PARENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 38 SWITZERLAND HOME PARENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 39 POLAND HOME PARENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 40 GERMANY HOME PARENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 41 SWITZERLAND HOME PARENTERAL NUTRITION IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 42 POLAND SERVICES IN HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY SERVICES, 2022-2031 (USD THOUSAND)
TABLE 43 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 44 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 45 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
List of Figure
FIGURE 1 POLAND, GERMANY AND SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: SEGMENTATION
FIGURE 2 POLAND, GERMANY AND SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: DATA TRIANGULATION
FIGURE 3 POLAND, GERMANY AND SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: DROC ANALYSIS
FIGURE 4 SWITZERLAND
FIGURE 5 GERMANY
FIGURE 6 POLAND
FIGURE 7 POLAND, GERMANY AND SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 8 POLAND, GERMANY AND SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 POLAND, GERMANY AND SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 POLAND, GERMANY AND SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: DBMR MARKET POSITION GRID
FIGURE 11 POLAND, GERMANY AND SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: VENDOR SHARE ANALYSIS
FIGURE 12 POLAND, GERMANY AND SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: SEGMENTATION
FIGURE 13 COUNTRY REVENUE, R&D EXPENDITURE AND MAJOR KEY PLAYERS
FIGURE 14 SWITZERLAND
FIGURE 15 GERMANY
FIGURE 16 POLAND
FIGURE 17 GERMANY
FIGURE 18 SWITZERLAND
FIGURE 19 POLAND
FIGURE 20 SEGMENT COMARISON OF SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET
FIGURE 21 SEGMENT COMARISON OF POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET
FIGURE 22 SEGMENT COMARISON OF GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET
FIGURE 23 PREVALENCE DATA, HPN
FIGURE 24 PREVALENCE DATA, HEN
FIGURE 25 PATIENT TYPE, HPN
FIGURE 26 PATIENT TYPE, HEN
FIGURE 27 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF POLAND, GERMANY AND SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET
FIGURE 28 MALNUTRITION RATE IN POLAND, GERMANY AND SWITZERLAND
FIGURE 29 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PATIENT TYPE, 2023
FIGURE 30 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PATIENT TYPE, 2023
FIGURE 31 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PATIENT TYPE, 2023
FIGURE 32 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PATIENT TYPE, 2024-2031 (USD THOUSAND)
FIGURE 33 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PATIENT TYPE, 2024-2031 (USD THOUSAND)
FIGURE 34 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PATIENT TYPE, 2024-2031 (USD THOUSAND)
FIGURE 35 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PATIENT TYPE, CAGR (2024-2031)
FIGURE 36 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PATIENT TYPE, CAGR (2024-2031)
FIGURE 37 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PATIENT TYPE, CAGR (2024-2031)
FIGURE 38 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PATIENT TYPE, LIFELINE CURVE
FIGURE 39 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PATIENT TYPE, LIFELINE CURVE
FIGURE 40 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PATIENT TYPE, LIFELINE CURVE
FIGURE 41 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY CARE TYPE, 2023
FIGURE 42 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY CARE TYPE, 2023
FIGURE 43 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY CARE TYPE, 2023
FIGURE 44 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY CARE TYPE, 2024-2031 (USD THOUSAND)
FIGURE 45 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY CARE TYPE, 2024-2031 (USD THOUSAND)
FIGURE 46 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY CARE TYPE, 2024-2031 (USD THOUSAND)
FIGURE 47 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY CARE TYPE, CAGR (2024-2031)
FIGURE 48 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY CARE TYPE, CAGR (2024-2031)
FIGURE 49 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY CARE TYPE, CAGR (2024-2031)
FIGURE 50 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY CARE TYPE, LIFELINE CURVE
FIGURE 51 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY CARE TYPE, LIFELINE CURVE
FIGURE 52 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY CARE TYPE, LIFELINE CURVE
FIGURE 53 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET : BY PRODUCT & SERVICES, 2023
FIGURE 54 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET : BY PRODUCT & SERVICES, 2023
FIGURE 55 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET : BY PRODUCT & SERVICES, 2023
FIGURE 56 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PRODUCT & SERVICES, 2024-2031 (USD THOUSAND)
FIGURE 57 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PRODUCT & SERVICES, 2024-2031 (USD THOUSAND)
FIGURE 58 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PRODUCT & SERVICES, 2024-2031 (USD THOUSAND)
FIGURE 59 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PRODUCT & SERVICES, CAGR (2024-2031)
FIGURE 60 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PRODUCT & SERVICES, CAGR (2024-2031)
FIGURE 61 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PRODUCT & SERVICES, CAGR (2024-2031)
FIGURE 62 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE
FIGURE 63 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE
FIGURE 64 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE
FIGURE 65 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 66 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 67 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 68 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND)
FIGURE 69 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND)
FIGURE 70 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND)
FIGURE 71 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 72 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 73 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 74 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 75 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 76 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 77 GERMANY HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: COMPANY SHARE 2023 (%)
FIGURE 78 SWITZERLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: COMPANY SHARE 2023 (%)
FIGURE 79 POLAND HOME PARENTERAL NUTRITION (HPN) AND HOME ENTERAL NUTRITION (HEN) MARKET: COMPANY SHARE 2023 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.